
OPKO Health OPK
$ 1.16
-0.43%
Quarterly report 2025-Q2
added 07-31-2025
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
694 M |
Market Cap[1] |
$ 805 M |
EBITDA (LTM) |
$ -79.8 M |
P/E (LTM) |
-4.46 |
P/S (LTM) |
1.22 |
EPS (LTM) |
-0.26 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 115.38 | 0.26 % | $ 35.1 B | NYSE,SPB | ||
|
BioNano Genomics
BNGO
|
$ 1.13 | - | $ 6.15 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 15.65 | -2.86 % | $ 168 M | Nasdaq Global Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 16.19 | 0.87 % | $ 863 M | Nasdaq Global Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Co-Diagnostics
CODX
|
$ 1.38 | 0.36 % | $ 1.84 M | Nasdaq Capital Market | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 2.3 | - | $ 10.2 M | Nasdaq Global Select Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Castle Biosciences
CSTL
|
$ 23.22 | 0.39 % | $ 645 M | Nasdaq Global Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
Charles River Laboratories International
CRL
|
$ 174.38 | -0.74 % | $ 8.64 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 498.0 | 0.91 % | $ 14.4 B | Nasdaq Global Select Market,SPB | ||
|
Danaher Corporation
DHR
|
$ 189.16 | -0.22 % | $ 135 B | NYSE,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Illumina
ILMN
|
$ 121.65 | 0.6 % | $ 19.3 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.37 | 0.34 % | $ 405 M | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 7.79 | 1.3 % | $ 998 M | Nasdaq Global Select Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 14.67 | 1.66 % | $ 444 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 79.04 | 0.55 % | $ 9.91 B | Nasdaq Global Select Market,SPB | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Anixa Biosciences
ANIX
|
$ 2.73 | 1.49 % | $ 88.6 K | Nasdaq Capital Market | ||
|
Biomerica
BMRA
|
$ 2.08 | -2.8 % | $ 4.78 M | Nasdaq Capital Market | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 28.22 | -0.3 % | $ 20 B | NYSE | ||
|
ICON Public Limited Company
ICLR
|
$ 107.7 | 0.83 % | $ 8.88 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 260.87 | -0.02 % | $ 21.7 B | NYSE,SPB | ||
|
Natera
NTRA
|
$ 196.81 | 1.96 % | $ 19.4 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 120.91 | 3.22 % | $ 5.65 B | Nasdaq Global Select Market | ||
|
Lantheus Holdings
LNTH
|
$ 80.04 | -0.68 % | $ 5.4 B | Nasdaq Global Select Market,SPB | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Senseonics Holdings
SENS
|
$ 6.54 | -2.1 % | $ 273 M | NYSE American | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 191.24 | -0.15 % | $ 21.2 B | NYSE,SPB | ||
|
Neogen Corporation
NEOG
|
$ 9.16 | -2.79 % | $ 1.99 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 52.56 | -0.13 % | $ 2.67 B | Nasdaq Capital Market | ||
|
ENDRA Life Sciences
NDRA
|
$ 5.0 | 1.21 % | $ 3.94 M | Nasdaq Global Select Market | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.